Page last updated: 2024-08-22

clodronic acid and Hyperparathyroidism

clodronic acid has been researched along with Hyperparathyroidism in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-199012 (70.59)18.7374
1990's1 (5.88)18.2507
2000's4 (23.53)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ala-Houhala, I; Kleimola, T; Pasternack, A; Saha, H; Ylitalo, P1
Brandi, ML; Ghinoi, V1
Ammann, P; Herter-Clavel, C; Lubrano, A; Rizzoli, R1
Blasco Huelva, A; González Palomino, A; Keituqwa Yáñez, T; Marcos García, M; Pantoja Hernández, CG; Pardo Romero, G; Pino Rivero, V; Trinidad Ruiz, G1
Douglas, DL; Duckworth, T; Kanis, JA; Prenton, MA; Preston, CJ; Preston, FE; Russell, RG; Woodhead, JS1
Beard, DJ; Cameron, EC; Douglas, DL; Kanis, JA; Paterson, AD; Russell, RG; Watson, ME; Williams, J; Woodhead, S1
Blomqvist, C; Elomaa, I; Holmström, T; Laine, H; Porkka, L1
Baron, R; Hayslett, JP; Jaeger, P; Jones, W1
Delmas, PD; Meunier, PJ1
Baquiran, DC; Bilezikian, JP; Shane, E1
Raisz, LG1
Groebli, Y; Hoffmeyer, P; Jung, A; Spiliopoulos, A1
Adami, S; Bertoldo, F; Jayawerra, P; Lo Cascio, V; Mian, M; O'Riordan, JL; Rossini, M1
Bijvoet, OL; Cleton, FJ; Elte, JW; Sleeboom, HP; van Oosterom, AT1
Brown, CB; Galloway, J; Gray, RE; Hamdy, NA; Kanis, JA; McCloskey, E; Rattenbury, JM1
Fleisch, H1

Reviews

3 review(s) available for clodronic acid and Hyperparathyroidism

ArticleYear
Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders.
    Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:11

    Topics: Antimetabolites; Bone and Bones; Bone Diseases; Bone Remodeling; Clinical Trials as Topic; Clodronic Acid; Drug Evaluation, Preclinical; Humans; Hyperkalemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans; Osteoporosis

2002
Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:4

    Topics: Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Osteolysis

1986
[Biphosphonate as a therapeutic drug--experimental studies and clinical application].
    Therapeutische Umschau. Revue therapeutique, 1985, Volume: 42, Issue:6

    Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Myositis Ossificans; Osteitis Deformans; Osteolysis; Osteoporosis; Pamidronate; Urinary Calculi

1985

Trials

2 trial(s) available for clodronic acid and Hyperparathyroidism

ArticleYear
Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
    Annals of internal medicine, 1981, Volume: 95, Issue:1

    Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Cyclic AMP; Diphosphonates; Female; Humans; Hydroxyproline; Hyperparathyroidism; Male; Middle Aged; Phosphates

1981
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment.
    Clinical endocrinology, 1990, Volume: 33, Issue:3

    Topics: Adult; Aged; Bone Resorption; Calcium; Clodronic Acid; Feedback; Female; Homeostasis; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Time Factors

1990

Other Studies

12 other study(ies) available for clodronic acid and Hyperparathyroidism

ArticleYear
Skeletal deposition of clodronate is related to parathyroid function and bone turnover in dialysis patients.
    Clinical nephrology, 2002, Volume: 58, Issue:1

    Topics: Adult; Aged; Bone and Bones; Bone Remodeling; Clodronic Acid; Female; Humans; Hyperparathyroidism; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis

2002
A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism.
    Aging clinical and experimental research, 2003, Volume: 15, Issue:6

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antimetabolites; Bone and Bones; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; Pamidronate; Retrospective Studies; Treatment Outcome

2003
[Association between primary hyperparathyroidism and Paget's disease. Report of a case].
    Anales otorrinolaringologicos ibero-americanos, 2005, Volume: 32, Issue:4

    Topics: Aged; Antimetabolites; Calcitonin; Clodronic Acid; Female; Humans; Hyperparathyroidism; Lumbar Vertebrae; Osteitis Deformans; Parathyroid Neoplasms; Tomography, X-Ray Computed

2005
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
    Lancet (London, England), 1980, May-17, Volume: 1, Issue:8177

    Topics: Alkaline Phosphatase; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans

1980
Medical management of primary hyperparathyroidism.
    Lancet (London, England), 1984, Sep-29, Volume: 2, Issue:8405

    Topics: Aged; Clodronic Acid; Estrogens; Etidronic Acid; Humans; Hyperparathyroidism; Middle Aged

1984
Drug treatment of primary hyperparathyroidism: use of clodronate disodium.
    British medical journal (Clinical research ed.), 1983, Feb-19, Volume: 286, Issue:6365

    Topics: Aged; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hyperparathyroidism; Male; Middle Aged

1983
Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
    Cancer treatment reports, 1984, Volume: 68, Issue:4

    Topics: Aged; Blood Chemical Analysis; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Female; Follow-Up Studies; Humans; Hyperparathyroidism; Middle Aged; Osteoclasts; Radionuclide Imaging; Urine

1984
Modulation of hypercalcemia by dichloromethane diphosphonate and by calcitonin in a model of chronic primary hyperparathyroidism in rats.
    Progress in clinical and biological research, 1984, Volume: 168

    Topics: Animals; Calcitonin; Clodronic Acid; Diphosphonates; Hypercalcemia; Hyperparathyroidism; Male; Parathyroid Hormone; Rats; Rats, Inbred Strains; Thyroidectomy

1984
[Diphosphonates in the treatment of hypercalcemia].
    La Revue de medecine interne, 1984, Volume: 5, Issue:4

    Topics: Bone Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Pamidronate

1984
New diphosphonates to block bone resorption.
    The New England journal of medicine, 1980, Feb-07, Volume: 302, Issue:6

    Topics: Animals; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Multiple Myeloma; Osteitis Deformans; Osteoclasts; Osteolysis; Osteomalacia; Propanolamines

1980
[[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
    Schweizerische medizinische Wochenschrift, 1982, Jan-23, Volume: 112, Issue:4

    Topics: Aged; Clodronic Acid; Diphosphonates; Drug Evaluation; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; Middle Aged

1982
Clodronate in the medical management of hyperparathyroidism.
    Bone, 1987, Volume: 8 Suppl 1

    Topics: Administration, Oral; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Infusions, Intravenous

1987